The company was established with Arab investment in 2007 and is considered the largest in Sudan for the production of veterinary and human medicines, designed and built to the highest standards in accordance with the best international practices and standards in the pharmaceutical manufacturing field. The company’s registered and paid-up capital is approximately 2,185 million Sudanese pounds, with ACDIMA holding a 40% stake in the company’s capital. The company’s factory is designed with three different production lines equipped with the latest advanced devices and equipment: an injectable production line, an oral liquid products production line, and a solid products production line. It produces antibiotics, anti-parasitic medications, monoclonal antibodies, steroidal anti-inflammatory drugs, vitamins, and mineral salts to cover Sudanese territories and neighboring countries. Due to the events in Sudan, a provision was made for the full value of ACDIMA investment, amounting to 4.5 million Kuwaiti dinars.